Halozyme Therapeutics (HALO) Q4 2015 Earnings

9NovConfirmed
Q1 2015
Q2 2015
Q3 2015
Q4 2015
-0.19
-0.12
-0.05
0.02

Details

Expected EPS
-0.17
Actual EPS
-0.19
Surprise EPS
-0.02
Surprise Percent
+11.76%

Description

Halozyme Therapeutics (HALO) has reported earnings of -0.19 per share for Q4 2015.

0 Comments

Share your thoughts